Subcutaneous Tocilizumab for Cystoid Macular Edema Secondary to Juvenile Idiopathic Arthritis (JIA)-associated Uveitis: A Case Report

被引:4
作者
Adan, Alfredo [1 ]
Moll-Udina, Aina [1 ]
Ramirez, Julio [2 ]
Llorenc, Victor [1 ]
机构
[1] Hosp Clin Barcelona, Dept Ophthalmol, Calle Sabino de Arana 1, E-08036 Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Rheumatol, Barcelona, Spain
关键词
uveitis; juvenile idiopathic arthritis; cystoid macular edema; tocilizumab; subcutaneous;
D O I
10.1080/09273948.2019.1644350
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To report a case of cystoid macular edema (CME) secondary to juvenile idiopathic arthritis (JIA)-associated uveitis. Case report: 26-year-old female patient presented with CME in both eyes. CME became refractory and TCZ-IV was initiated. After 12 infusions was stopped because grade 1 neuropenia developed. On examination,visual acuity of the right eye was 20/80. Spectral domain optical coherence tomography (SD-OCT) of the right eye revealed CME. Subcutaneous (TCZ-SC) was initiated. After six injections of TCZ-SC, ophthalmic examination revealed no signs of active inflammation, and central foveal thickness decreased. Conclusion: TCZ-SC seems to have a role in the treatment of CME secondary to juvenile idiopathic arthritis (JIA)-associated uveitis
引用
收藏
页码:6 / 8
页数:3
相关论文
共 6 条
[1]   Tocilizumab treatment for refractory uveitis-related cystoid macular edema [J].
Adan, Alfredo ;
Mesquida, Marina ;
Llorenc, Victor ;
Espinosa, Gerard ;
Molins, Blanca ;
Hernandez, Maria V. ;
Pelegrin, Laura .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (11) :2627-2632
[2]   Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study [J].
Darloy, Jean ;
Segaud, Nicolas ;
Salmon, Jean-Hugues ;
Eschard, Jean-Paul ;
Goeb, Vincent ;
Deprez, Xavier ;
Guyot, Marie-Helene ;
Houvenagel, Eric ;
Lecuyer, Nicolas ;
Marguerie, Laurent ;
Gally, Samuel ;
Pau, David ;
Idier, Isabelle ;
Baudens, Guy ;
Flipo, Rene-Marc .
RHEUMATOLOGY AND THERAPY, 2019, 6 (01) :61-75
[3]   Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis [J].
De Benedetti, Fabrizio ;
Brunner, Hermine I. ;
Ruperto, Nicolino ;
Kenwright, Andrew ;
Wright, Stephen ;
Calvo, Inmaculada ;
Cuttica, Ruben ;
Ravelli, Angelo ;
Schneider, Rayfel ;
Woo, Patricia ;
Wouters, Carine ;
Xavier, Ricardo ;
Zemel, Lawrence ;
Baildam, Eileen ;
Burgos-Vargas, Ruben ;
Dolezalova, Pavla ;
Garay, Stella M. ;
Merino, Rosa ;
Joos, Rik ;
Grom, Alexei ;
Wulffraat, Nico ;
Zuber, Zbigniew ;
Zulian, Francesco ;
Lovell, Daniel ;
Martini, Alberto .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25) :2385-2395
[4]   TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS- RELATED MACULAR EDEMA [J].
Mesquida, Marina ;
Molins, Blanca ;
Llorenc, Victor ;
Hernandez, Maria V. ;
Espinosa, Gerard ;
Sainz De la Maza, Maite ;
Adan, Alfredo .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (07) :1361-1370
[5]   Subcutaneous Tocilizumab May Be Less Effective than Intravenous Tocilizumab in the Treatment of Juvenile Idiopathic Arthritis-associated Uveitis [J].
Quesada-Masachs, Estefania ;
Modesto Caballero, Consuelo .
JOURNAL OF RHEUMATOLOGY, 2017, 44 (02) :260-261
[6]   Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis [J].
Tappeiner, Christoph ;
Mesquida, Marina ;
Adan, Alfredo ;
Anton, Jordi ;
Ramanan, Athimalaipet V. ;
Carreno, Ester ;
Mackensen, Friederike ;
Kotaniemi, Kaisu ;
de Boer, Joke H. ;
Bou, Rosa ;
Garcia de Vicuna, Carmen ;
Heiligenhaus, Arnd .
JOURNAL OF RHEUMATOLOGY, 2016, 43 (12) :2183-2188